Showing results (241-250 of 271) with videos related to

Sort By:
Pageof 28
Cancer Discovery|April 11, 2021
Oncogenic <i>KRAS</i> Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer MetastasisMichael P Kim, Xinqun Li, Jenying Deng, et al.
Cancer Research|September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal AdenocarcinomaCarla Mottini, Hideo Tomihara, Diego Carrella, et al.
Cancer Research|October 21, 2016
Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated MethylationYan Wang, Jung-Mao Hsu, Ya'an Kang, et al.
Molecular Metabolism|December 31, 2021
CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loopYihui Chen, Michela Capello, Mayrim V Rios Perez, et al.
JAMA Surgery|July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Huamin Wang, Michael E Egger, et al.
JCO Precision Oncology|September 11, 2020
Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic CancerEugene J Koay, Matthew H G Katz, Huamin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
4-1BB Agonist Focuses CD8<sup>+</sup> Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic CancerDonastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, et al.
International Journal of Molecular Sciences|December 17, 2024
Molecular Pathway and Immune Profile Analysis of IPMN-Derived Versus PanIN-Derived Pancreatic Ductal AdenocarcinomasMargaret A Park, Kristyn Gumpper-Fedus, Somashekar G Krishna, et al.
The Journal of Clinical Investigation|March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and responseEugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Cancer Research|March 5, 2015
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerPiergiorgio Pettazzoni, Andrea Viale, Parantu Shah, et al.
Pageof 28